The WHO's emergency use authorisation (EUA) for Bharat Biotech's COVID-19 vaccine Covaxin has reportedly been delayed by a few weeks as the agency sent more technical queries to the vaccine maker. "It's the usual process," a WHO official was quoted as saying. The delay is likely to affect students, medical tourists, business travellers and those who want to travel abroad.